Drawing for INCADA

USPTO serial 98913504

INCADA

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
WILLIS, ALLYSON B
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with INCADA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia K. Sutherland

Julia K. Sutherland SEYFARTH SHAW LLP233 SOUTH WACKER DRIVESUITE 8000CHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for processing, managing, retrieving and storing health, medical, and pharmaceutical data and medical device and medical diagnostic instrument operational data, and hosting applications in the fields of medicine, health, pharmaceuticals, medical devices and medical laboratory diagnostic instruments; downloadable software for use in collecting information and data regarding pharmaceutical inventory, dispensing transactions, apparatus availability to optimize efficiency in the field of pharmaceuticals; downloadable software for use in the life sciences industry to enhance the efficiency of clinical diagnostics and laboratory operations and to improve patient outcomes by facilitating data analysis and workflow management across connected instruments and computer systems; downloadable software for analyzing health, medical, and pharmaceutical data and medical device data and medical diagnostic instrument data; electronic control devices, apparatus and computer hardware for storing and dispensing pharmaceuticals, and parts and fittings thereforACTIVE—
010Medical devices, namely a full line of medical devices and instruments for use in surgery and surgical apparatus and instruments for medical use; medical devices, namely infusion and injection devices for administering drugs, infusion pumps and controllers, namely, volumetric infusion pumps, syringe pumps, programmable infusion pumps, programmable syringe pumps and the resident control programs; clinical vital signs measurement instruments, namely, thermometers for medical use, disposable thermometer covers, blood pressure measurement instruments, pulse rate measurement instruments, blood pressure cuffs, pulse oximetry instruments, namely, sensors and monitors, respiration measurement instruments, and ecg instruments in the nature of electrocardiographic recorders; medical fluid administration sets for the delivery of medical fluids, namely, drug delivery tubing, clamps, flow control devices, drug infusion connectors, adapters, injection sites, needleless connectors, needleless ports, needleless injection sites, and medical valves; medical devices for the delivery of medical fluids, namely, drug delivery tubing, clamps, flow control devices, drug infusion connectors, adapters, injection sites, needleless connectors, needleless ports, needleless injection sites, and medical valves; intravenous fluid containers sold empty, monitors, alarms, rate meters; sphygmomanometers; enteric infusion pumps and bags, sold empty, therefor; medical instrument and intravenous fluid container stands and hanger devices in the nature of intravenous stands and poles and stands and hangers specifically adapted for patient infusion systems consisting primarily of infusion pumps and controllers; patient monitors for critical care; medical apparatus and instruments for patient monitoring; medical apparatus and instruments for monitoring patient hemodynamics and oxygen saturation; medical diagnostic equipment, namely, medical instruments for the detection of infectious diseases, and parts and fittings therefor; medical diagnostic equipment, namely, medical instruments for the analysis of body fluid, and parts and fittings thereforACTIVE—
042Platform as a service (PAAS) featuring computer software platforms for processing, managing, retrieving and storing health, medical and medical device and medical diagnostic instrument operational data and hosting applications in the fields of medicine, health, pharmaceuticals, medical devices and medical laboratory diagnostic instruments; Platform as a service (PAAS) featuring computer software platforms for use in collecting information and data regarding pharmaceutical inventory, dispensing transactions, apparatus availability to optimize efficiency in the field of pharmaceuticals; Platform as a service (PAAS) featuring computer software platforms for use to enhance the efficiency of clinical diagnostics and laboratory operations and to improve patient outcomes by facilitating data analysis and workflow management across connected instruments and computer systems in the fields of medicine, health, pharmaceuticals, medical devices and medical laboratory diagnostic instruments; software as a service (SAAS) featuring software for analyzing medical and medical device and medical diagnostic instrument operational data and hosting applications in the fields of medicine, health, pharmaceuticals, medical devices and medical laboratory diagnostic instruments; software as a service (SAAS) featuring software for use in collecting information and data regarding pharmaceutical inventory, dispensing transactions, apparatus availability to optimize efficiency in the field of pharmaceuticals; software as a service (SAAS) featuring software for use to enhance the efficiency of clinical diagnostics and laboratory operations and to improve patient outcomes by facilitating data analysis and workflow management across connected instruments and computer systems in the fields of medicine, health, pharmaceuticals, medical devices and medical laboratory diagnostic instruments; platform as a service (PAAS) featuring computer software platforms for analysing health, medical, and pharmaceutical data and medical device and medical diagnostic instrument data; software as a service (SAAS) featuring software for analysing health, medical, and pharmaceutical data and medical device and medical diagnostic instrument dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 26, 2026EX2GSOU EXTENSION 2 GRANTED—
Oct 26, 2026EXT2SOU EXTENSION 2 FILED—
Oct 26, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2026EX1GSOU EXTENSION 1 GRANTED—
May 14, 2026EXT1SOU EXTENSION 1 FILED—
May 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 29, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 28, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2025DOCKASSIGNED TO EXAMINER—
Apr 27, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance